ZEISS launches phakic intraocular lens in China with local manufacturing
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
What happened
ZEISS showcased its next-generation aspheric phakic intraocular lens, PT LUNANA, at the China International Import Expo in Shanghai. The lens received approval from China's National Medical Products Administration (NMPA). The product was developed by Wuxi Carl Zeiss Vision Pro Medical Technology Co., Ltd., a joint venture of ZEISS in China, and is set to be manufactured locally.
From finanznachrichten.de
Why it matters
The NMPA approval and the establishment of local manufacturing signal strong market confidence in China's medical technology sector. The new lens is designed to address myopia, a growing public health challenge in China, where an estimated 600 million people have the condition.
From finanznachrichten.de
Who's involved
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- ChinaSpeculative
The medical technology industry might see increased investment due to the regulatory approval and local manufacturing expansion.